Digital Pathology Gives Rise to Computational Pathology
Artificial intelligence is reshaping the capabilities and practices of modern pathology laboratories.
Read More
Search Results for: prostate cancer
Bio-Rad Adds New Analytes to Tumor Marker Control
The updated control has received FDA premarket notification (510(k)) clearance and CE marking, and is available for the immunoassay-based tumor marker testing market.
Read MoreLiquid Biopsy at a Glance
A number of oncology centers have developed and implemented liquid biopsy tests not only for lung cancer, but for breast, colorectal, gynecologic, ovarian, prostate, and skin cancers as well.
Read More
May 2017 Product Spotlight: Immunoassay Analyzers
This month’s issue features immunoassay analyzers from such companies as Arlington Scientific and Dynex Technologies.
Read More
Multiplexing at the Molecular Level
Molecular panel tests are making inroads against complex genetic diseases.
Read More